Molecular mechanisms in idiopathic inflammatory myopathies
Author: Zong, Mei
Date: 2014-10-10
Location: Föreläsningssalen CMM L8:00, Karolinska Universitetssjukhuset, Solna.
Time: 09.00
Department: Inst för medicin, Solna / Dept of Medicine, Solna
Abstract
Background: Myositis is a group of rare autoimmune diseases. Muscle weakness and fatigue
are the dominant symptoms and inflammation with T cells and macrophages is a
characteristic finding in muscle tissue. Currently high-dose and long-term glucocorticoids is
still the most important treatment but with limited efficacy and worrisome side effects.
Therefore, investigations regarding inflammatory mediators and their roles in myositis
pathogenesis are important in order to develop new therapies.
Methods: In order to investigate the roles of different inflammatory mediators in patients with myositis, biological samples were investigated from clinically well-characterized patients in different phases of disease. Several techniques were employed: immunohistochemical staining on muscle tissue and cultured skeletal muscle cells; flow cytometry, ELISA and chemiluminescence immunoassay on blood samples. Hypotheses regarding molecular mechanisms for muscle weakness and fatigue were tested in animal models, where we mainly used enzymatically dissociated muscle fibers and mechanically dissected muscle fibers to measure the force and calcium release from the sarcoplasmic reticulum under various defined molecular conditions.
Results: Based on previous observations on IL-1 expression in muscle tissue we first tested the role of IL-1 by using IL-1 blockade, anakinra, for 12 months in patients with refractory myositis. Eight of 15 patients had a clinical response which correlated to some response in biomarkers in blood, but muscle tissue inflammation persisted. Therefore, we searched for a new immune modulating target and found IL-15 to be expressed in muscle tissue of patients with myositis, and higher IL-15 expression was associated with more muscle dysfunction. Another approach was to test for the role of inflammatory molecules in early phases of muscle inflammation. In this context the extra nuclear presence of the alarmin high-mobility group box 1 (HMGB1) in the muscle fibers of patients with myositis without detectable inflammatory infiltrates is of interest. By in vitro experiments we showed that HMGB1 can influence muscle function by accelerating muscle fatigue and inducing MHC-class I expression via TLR4. Another receptor for HMGB1, TLR2, was also found in muscle tissue of patients with myositis and our animal study demonstrated that by knocking out TLR2 the skeletal muscle fibers became more muscle fatigue resistant.
Conclusion: Collectively, the investigations in my thesis suggest that inflammatory mediators play important roles in the pathogenesis of myositis and different molecules may contribute in different phases of disease. Hereby, HMGB1 might induce muscle dysfunction at an early stage of the disease via TLR4 (or/and TLR2). IL-15 could be involved in developing muscle dysfunction via maintaining T cell homeostasis in the muscles. IL-1 may be important in a subset of patients by driving the adaptive immune system. However, more studies are needed for a comprehensive understanding of their roles in order to develop new therapies.
Methods: In order to investigate the roles of different inflammatory mediators in patients with myositis, biological samples were investigated from clinically well-characterized patients in different phases of disease. Several techniques were employed: immunohistochemical staining on muscle tissue and cultured skeletal muscle cells; flow cytometry, ELISA and chemiluminescence immunoassay on blood samples. Hypotheses regarding molecular mechanisms for muscle weakness and fatigue were tested in animal models, where we mainly used enzymatically dissociated muscle fibers and mechanically dissected muscle fibers to measure the force and calcium release from the sarcoplasmic reticulum under various defined molecular conditions.
Results: Based on previous observations on IL-1 expression in muscle tissue we first tested the role of IL-1 by using IL-1 blockade, anakinra, for 12 months in patients with refractory myositis. Eight of 15 patients had a clinical response which correlated to some response in biomarkers in blood, but muscle tissue inflammation persisted. Therefore, we searched for a new immune modulating target and found IL-15 to be expressed in muscle tissue of patients with myositis, and higher IL-15 expression was associated with more muscle dysfunction. Another approach was to test for the role of inflammatory molecules in early phases of muscle inflammation. In this context the extra nuclear presence of the alarmin high-mobility group box 1 (HMGB1) in the muscle fibers of patients with myositis without detectable inflammatory infiltrates is of interest. By in vitro experiments we showed that HMGB1 can influence muscle function by accelerating muscle fatigue and inducing MHC-class I expression via TLR4. Another receptor for HMGB1, TLR2, was also found in muscle tissue of patients with myositis and our animal study demonstrated that by knocking out TLR2 the skeletal muscle fibers became more muscle fatigue resistant.
Conclusion: Collectively, the investigations in my thesis suggest that inflammatory mediators play important roles in the pathogenesis of myositis and different molecules may contribute in different phases of disease. Hereby, HMGB1 might induce muscle dysfunction at an early stage of the disease via TLR4 (or/and TLR2). IL-15 could be involved in developing muscle dysfunction via maintaining T cell homeostasis in the muscles. IL-1 may be important in a subset of patients by driving the adaptive immune system. However, more studies are needed for a comprehensive understanding of their roles in order to develop new therapies.
List of papers:
I. Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers. Mei Zong, Christina Dorph, Maryam Dastmalchi, Helene Alexanderson, Jennifer Pieper, Petra Amoudruz, Sevim Barbasso Helmers, Inger Nennesmo, Vivianne Malmström, Ingrid E. Lundberg. Ann Rheum Dis. 2014 May 1; 73(5):913-20.
Fulltext (DOI)
Pubmed
II. Effects of conventional immunosuppressive treatment on Interleukin-15 in muscle tissue of patients with polymyositis or dermatomyositis. Mei Zong, Ingela Loell, Eva Lindroos, Gustavo Nader, Helene Alexanderson, Christina Ståhl Hallengren, Kristian Borg, Snjolaug Arnardottir, Iain B Mclnnes and Ingrid Lundberg. Ann Rheum Dis. 2012 Jun; 71(6):1055-63
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Mei Zong, Joseph D. Bruton, Cecilia Grundtman, Huan Yang, Jian Hua Li, Helene Alexanderson, Karin Palmblad, Ulf Andersson, Helena E. Harris, Ingrid E. Lundberg and Håkan Westerblad. Ann Rheum Dis. 2013 Aug; 72(8):1390-9.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Loss of TLR2 increases fatigue resistance in mouse skeletal muscles Mei Zong, Arthur Cheng, Abram Katz, Niklas Ivarsson, Ingrid E. Lundberg, Håkan Westerblad, Helena E. Harris, Joseph D. Bruton. [Submitted]
I. Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers. Mei Zong, Christina Dorph, Maryam Dastmalchi, Helene Alexanderson, Jennifer Pieper, Petra Amoudruz, Sevim Barbasso Helmers, Inger Nennesmo, Vivianne Malmström, Ingrid E. Lundberg. Ann Rheum Dis. 2014 May 1; 73(5):913-20.
Fulltext (DOI)
Pubmed
II. Effects of conventional immunosuppressive treatment on Interleukin-15 in muscle tissue of patients with polymyositis or dermatomyositis. Mei Zong, Ingela Loell, Eva Lindroos, Gustavo Nader, Helene Alexanderson, Christina Ståhl Hallengren, Kristian Borg, Snjolaug Arnardottir, Iain B Mclnnes and Ingrid Lundberg. Ann Rheum Dis. 2012 Jun; 71(6):1055-63
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Mei Zong, Joseph D. Bruton, Cecilia Grundtman, Huan Yang, Jian Hua Li, Helene Alexanderson, Karin Palmblad, Ulf Andersson, Helena E. Harris, Ingrid E. Lundberg and Håkan Westerblad. Ann Rheum Dis. 2013 Aug; 72(8):1390-9.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Loss of TLR2 increases fatigue resistance in mouse skeletal muscles Mei Zong, Arthur Cheng, Abram Katz, Niklas Ivarsson, Ingrid E. Lundberg, Håkan Westerblad, Helena E. Harris, Joseph D. Bruton. [Submitted]
Institution: Karolinska Institutet
Supervisor: Lundberg, Ingrid
Issue date: 2014-09-19
Rights:
Publication year: 2014
ISBN: 978-91-7549-618-4
Statistics
Total Visits
Views | |
---|---|
Molecular ...(legacy) | 1004 |
Molecular ... | 269 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Molecular ... | 2 | 0 | 0 | 0 | 2 | 0 | 1 |
File Visits
Views | |
---|---|
Thesis_Mei_Zong.pdf(legacy) | 343 |
Thesis_Mei_Zong.pdf | 295 |
Spikblad_Mei_Zong.pdf(legacy) | 122 |
Spikblad_Mei_Zong.pdf | 22 |
spikbladet_Mei Zong.pdf(legacy) | 3 |
Kappa_Mei Zong.pdf(legacy) | 2 |
Top country views
Views | |
---|---|
China | 291 |
United States | 211 |
Sweden | 162 |
Germany | 135 |
Ireland | 12 |
South Korea | 11 |
France | 9 |
Finland | 7 |
Russia | 7 |
Denmark | 6 |
Top cities views
Views | |
---|---|
Shenzhen | 187 |
Ashburn | 47 |
Kiez | 45 |
Stockholm | 33 |
Sunnyvale | 29 |
Beijing | 27 |
Dublin | 11 |
Seoul | 11 |
Tianjin | 6 |
Baltimore | 4 |